2015 NCCN Oncology Fellows Program: New Horizons in Quality Cancer Care

Hollywood, FL US
March 15, 2015

The purpose of this well-regarded program is to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology™ and other evidence-based treatment principles in the management of significant cancer types and supportive care issues. The NCCN Oncology Fellows Program has established itself as a premier career-enhancing event for oncology fellows across the United States.

Target Audience

This educational program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.

Learning Objectives

Following this program, participants should be able to:

Evolving Treatment Strategies for Triple Negative Breast Cancer

  • Compare current treatment options for triple negative breast cancer
  • Discuss future directions in the treatment of triple negative breast cancer

Advances in the Management of Brain Metastases

  • Identify patient selection criteria for stereotactic surgery for brain metastases
  • Evaluate systemic treatment options available to patients with recurrent brain metastases

Peripheral T-cell Lymphomas: Evolving Treatment Options

  • Summarize the current and evolving treatment options for the treatment of PTCL
  • Develop an evidence-based treatment plan integrating novel agents for the management of newly diagnosed and relapsed PTCL

Multidisciplinary Management of Locoregional Non-Small Cell Lung Cancer

  • Describe the need for multidisciplinary evaluation in managing patients with non small cell lung cancer who have locoregional disease
  • Employ the use of adjuvant or neoadjuvant therapy for patients with non small cell lung cancer who have locoregional disease 

Academia or the Community: Selecting the Right Practice Setting for You  

  • Compare and contrast the advantages and disadvantages of community vs. academic oncology practice
  • Identify requirements and formulate strategies for a successful academic career
Additional information
Supporters: 

This activity is supported by a grant from AstraZeneca.

This activity is supported by educational grants from:

  • Genentech BioOncology
  • Spectrum Pharmaceuticals, Inc.
  • Takeda Oncology
Course summary
Available credit: 
  • 0.00 Participation
  • 0.00 Physician
Course opens: 
03/15/2015
Course expires: 
04/30/2015
Event starts: 
03/15/2015 - 7:30am
Event ends: 
03/15/2015 - 11:30am
Cost:
$0.00
The Diplomat
3555 S. Ocean Drive
Hollywood, FL 33019
United States

Available Credit

  • 0.00 Participation
  • 0.00 Physician

Accreditation Period

Course opens: 
03/15/2015
Course expires: 
04/30/2015

Price

Cost:
$0.00
Please login or register to take this course.